Connect with us

Featured

Where Is Healthcare Headed?

Daniel Chase

Published

on

biotech stocks to watch

Of all the industries undergoing rapid growth through innovative efforts, the healthcare sector is one such field where advancements are crucially necessary for the future of the industry. Whereas other industries manufacture products and services that assist consumers in making their lives easier, all of those fall to the wayside if a person’s healthcare is not in good shape.

As the global population begins to both increase in number and age, more and more people are in need of personalized healthcare and treatment tailored to their specific needs. Diseases have become far too advanced for patients to take a “one-pill-cures-all” treatment and hope for the best. Medical experts and scientists are actually looking at a patient’s genetic makeup to determine how to best treat each individual person. 

Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond

While gathering information about each patient’s health history and hierarchy of needs is a step in the right direction, medical professionals simply do not have the bandwidth to sort through every piece of data to ultimately arrive to a decision for how to best take care of their patients. In both the healthcare sector and other industries, we’ve seen a massive shift towards investing in big data and analyzing information so that companies can cater their product offerings to meet exactly what consumers want. 

One such technology that has emerged as a tool for sorting through gargantuan amounts of patient data is the use of artificial intelligence systems. When used by healthcare providers, these AI systems have shown potential for transforming the diagnosis and treatment of diseases. Artificial intelligence drastically increases the capacity to analyze large and more complex sources of data, such as electronic health records of hundreds of patients, through the use of computers which have the ability to learn as they work. 

Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F)is a Canadian publicly traded company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies to provide the best possible care solutions for their patients. In full recognition of the potential opportunities presented by incorporating AI into healthcare systems, the Company has made key investments to lead the healthcare industry into the future. 

Earlier this month, Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F) announced that it is working with Bio Conscious Technologies (BCT) to bring their artificial intelligence technology to Premier Health’s user base. Premier Health will be partnering with BCT to enable patients and care providers improved monitoring of chronic disease progression and management of chronic conditions, such as diabetes, using BCT’s proprietary AI technology.

Following Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F)‘s collaboration announcement, Amir Hayeri, Chief Executive Officer of BCT, said, “we are excited to be selected by Premier Health to partner for our remote health monitoring technology. Incorporating the DiaBits technology platform into Premier Health’s app will reduce the guesswork associated with managing diabetes and result in diabetic users having fewer sugar highs, and fewer sugar lows, all while delaying the onset of complications. We are also in the works for developing similar technologies that predict high blood-pressure and premature contractions for pregnant women at risk of pre-eclampsia.”

Pursuant to an agreement between MIDAM VENTURES, LLC  and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 CASH for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). Midam has been compensated an additional $100,000 by Premier Health Group to extend the period of coverage to June 1, 2019. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. 

Continue Reading
Click to comment

Featured

Can Apple (AAPL) Stock Price Catch A Boost From AppleTV+?

Daniel Chase

Published

on

apple stock price AAPL

Apple Inc. (AAPL Stock Report) is growingly shifting its dependence on other categories of products as iPhone sales continue the decline. The biggest bets for the company involve services and at the beginning of the year, they introduced four new services that are Apple News+, The Apple Card, Apple Arcade and the Apple TV+.

Apple TV plus to debut in November

One of the services Apple TV+ subscription is expected to be launched in two months and it is seen as a competitor to streaming platform Netflix Inc. (NASDAQ: NFLX). For over two years Apple has been planning its entry into the TV subscription space. Early reports indicated that the company was planning to commit over $1 billion on programming to realize the venture.

The company plans to introduce a small collection of shows before expanding its catalog in months to follow. Sources familiar with the matter indicated that there is a possibility a free trial as the company continues to build its library. Apple will employ a different video subscription strategy for its shows with plans of offering the first three episodes of shows then followed by weekly installments.

Tech Stocks That Could Benefit From The Boom In New Streaming Stocks

The “Netflix and Chill” or now “Apple And Chill?” mentality of the new generation of viewers may have created an opportunity for certain niche sectors. One of these niche’s is on-demand delivery stocks. Amazon and Uber have entered the space with a significant focus on timeliness. However, as Uber puts it, UberEats may be the loss leader for the company due to the infrastructure. Furthermore, Amazon may be more insulated due to the sheer size of its core business.

This being said, it’s vital to look at companies that may be smaller, more nimble, and streamlined for potential profitability. In this regard, ParcelPal (PTNYF) (PKG) has been a company that we’ve discussed numerous times in the past. The company targets on-demand delivery of pretty much anything. But what has set it apart from the UberEats and Postmates of the world is their direct integration of cannabis.

Something that is beginning to set ParcelPal (PTNYF) (PKG) apart from its immediate competition is its diversification strategy. Not only is the company working with the likes of Amazon, but it is also entering into key verticals that are seeing an increase in rapid demand. Right now, ParcelPal (PTNYF) (PKG) has built relationships with businesses in both alcohol and cannabis.

We don’t have to go into the deep details of these booming industries, but it is vital to understand that the evolution from brick-and-mortar to on-demand delivery could be setting the stage for a major economic boom.

While consumers are becoming more comfortable with using smartphones and computers to buy groceries, they are also increasingly using the same technology to help them skip trips to the liquor store, according to data from the e-commerce analytics firm, Slice Intelligence. Netflix and Chill just got an upgrade!

Joining the competitive streaming space

Apple joins the growing number of providers offering streaming services such as Netflix, and Amazon.com Inc. (AMZN Stock Report), Walt Disney Co. (NYSE: DIS),Comcast Corp.’s (CMCSA Stock Report) NBCUniversal and AT&T Inc. (T Stock Report). These companies are all targeting the growing number of viewers who are watching on mobile devices or canceling cable TV subscriptions. 

The company has set aside $6 billion of its budget for the rolling out of TV+ subscription’s shows and movies. Apple is spending more money as it attempts to create more to achieve its goal of $50 billion in service sales by next year. The company is seeking new ways of generating revenue as smartphone sales continue to slow down due to market saturation and weak economies. 

Apple has not indicated the pricing of the service but it is expected to be around $9.99 per month. Netflix and Amazon charge $8.99 while Disney+ will charge $6.99 when its service becomes available in November.

apple stock price AAPL
Disclaimer: MIDAM VENTURES LLC has been compensated $75,000 per month by a ParcelPal Technology, Inc. for a period beginning September 1, 2018 and ending February 1, 2019 to publicly disseminate information about (PTNYF/PKG) to publicly disseminate information about (PTNYF/PKG). Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to April 1, 2019. Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to May 1, 2019. Midam Ventures has been compensated $200,000 by Parcel Pal and has extended coverage to June 1, 2019. Midam Ventures has been compensated $200,000 by Parcel Pal and has extended coverage to July 1, 2019. We may buy or sell additional shares of (PTNYF/PKG) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares. Click Here For Full Disclaimer

Continue Reading

Featured

Stock Price Wednesday Morning Update – August 21, 2019

Joe Samuel

Published

on

biotech stocks to watch

PharmaCyte Biotech to Hold Special Shareholder Meeting

PharmaCyte Biotech, Inc. (PMCB), a clinical-stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it will hold a Special Shareholder Meeting on September 11, 2019.

See More On This – CLICK HERE


Must Read Biotech Stock Report

With a wave of groundbreaking products in the pipeline, biotechnology could be poised to keep churning higher for the foreseeable future. But how can you get in on the ground floor of the next big wave in biotech?

Continue Reading


2 Food Delivery Stocks To Watch Before The End Of Summer

The food delivery industry in the United States has grown into a behemoth and although the margins are extremely thin, investors are willing to bet billions on some of the biggest food delivery companies. At this point in time, companies are fighting among themselves to gain supremacy in this space and competition is heating up as they look to grab market share from each other.

Read More Here


2 Chinese Stocks Making Bullish Moves

The trade war with the United States and an economic slowdown for the first time in three decades has cratered the markets in China. China-based stocks have generally underperformed over the course of the past year. But even during such a slowdown, some stock prices have been showing bullish tendencies. Here is a look at two such China-based companies that have seen stock prices climb.

See For Yourself

biotech stock to buy 2019

Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC and Complete Investment And Management LLC, a Non-affiliate Third Party, Midam was hired for a period from 07/09/2019 – 8/09/2019 to publicly disseminate information about PharmaCyte Biotech including on the Website and other media including Facebook and Twitter. We were paid $150,000 (CASH) for & were paid “0” shares of restricted common shares. We were paid an additional $150,000 (CASH) BY Complete Investment And Management LLC, a Non-affiliate Third Party, AND HAVE EXTENDED coverage for a period from 8/12/2019 – 9/12/2019. We may buy or sell additional shares of PharmaCyte Biotech in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer

Continue Reading

Featured

2 Chinese Stocks Making Bullish Moves

A. Lawrence

Published

on

chinese stock prices

The trade war with the United States and an economic slowdown for the first time in three decades has cratered the markets in China. China-based stocks have generally underperformed over the course of the past year. But even during such a slowdown, some stock prices have been showing bullish tendencies. Here is a look at two such China-based companies that have seen stock prices climb.

SINA Corp (SINA)

One of the stocks that recorded significant gains on Monday was that of SINA Corp (SINA Stock Report), the Chinese digital media company. The company announced its quarterly earnings yesterday and results proved to be hugely impressive. The company’s earnings for Q2 2019 stood at an impressive $0.73 per share while total sales rose to $533.1 million. It managed to beat analysts’ expectations of earnings of $0.47 per share and sales of $510.2 million in sales handsomely.

[Read More] 2 Food Delivery Stocks To Watch Before The End Of Summer

That being said, it needs to be pointed out that the company’s sales figures had actually declined by 1% year on year. However, the fact that it managed to beat estimates has proven to be a major trigger for the SINA stock. On Monday, the stock gained as much as 13% and should be in focus for the rest of the week.

Baidu Inc (BIDU)

The other Chinese stock that surged on Monday was that of tech giant Baidu Inc (BIDU Stock Report), which, like SINA, had managed to deliver better than expected earnings. The company had a disappointing Q1 2019 but has managed to bounce back in the second quarter by generating $3.83 billion in revenues and earnings per share of $1.47. The results also managed to beat the projections that the company had provided some months ago.

Considering the fact that the Chinese economy is currently in a slowdown, this is an acceptable earnings results for Baidu and hence the company’s stock rose by as much as 9% yesterday. It would be worthwhile to keep an eye on the stock for the foreseeable future.  

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


We keep all user information pricate & promise to never spam.*

Privacy Policy

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com